Stock Events

Stock Events

Kaken Pharmaceutical (4521.TSE) Q1 2025 Earnings

6FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

42

145

248

351

Details

Expected EPS

N/A

Actual EPS

124

Surprise EPS

124

Surprise Percent

+∞%

Description

Kaken Pharmaceutical (4521.TSE) has reported earnings of 124 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.